Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19
Clinical trial NCT04674566 · UNKNOWN
Trial details
- NCT number
- NCT04674566
- Sponsor
- Corat Therapeutics Gmbh
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2022-10-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.